Literature DB >> 3946749

Effect of cyclosporine on bile secretion in rats.

F S Rotolo, G D Branum, B A Bowers, W C Meyers.   

Abstract

Short-term effects of cyclosporine were studied in the isolated perfused rat liver model. Bile flow was inhibited by cyclosporine in 2 mg/kg and 20 mg/kg doses but not by a 0.2 mg/kg dose. Cholestasis was accompanied by a decrease in bile acid secretion, indicating an inhibitory effect on the bile acid-dependent fraction of bile flow. Perfusate bilirubin levels increased threefold in rat livers given 20 mg/kg of cyclosporine, but did not change in control animals. Alkaline phosphatase and transaminase levels did not differ from those of control animals. The isolated perfused rat liver was able to excrete cyclosporine, as demonstrated by a continual decrease in perfusate cyclosporine levels. No light microscopic evidence of cholestasis or hepatocellular damage was demonstrated on histologic staining. Our model appears to be a good one for the study of altered hepatic physiologic characteristics caused by administration of cyclosporine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946749     DOI: 10.1016/0002-9610(86)90008-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats.

Authors:  S Yasumiba; S Tazuma; H Ochi; K Chayama; G Kajiyama
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  Effect of pharmacological modulation of liver P-glycoproteins on cyclosporin A biliary excretion and cholestasis: a study in isolated perfused rat liver.

Authors:  M D Delle Monache; A Gigliozzi; A Benedetti; L Marucci; A Bini; C Francia; E Papa; E Di Cosimo; F Fraioli; A M Jezequel; D Alvaro
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 3.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine.

Authors:  W Hagmann; S Parthé; I Kaiser
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Liver injury from cyclosporine A.

Authors:  C Kassianides; R Nussenblatt; A G Palestine; S D Mellow; J H Hoofnagle
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

6.  Effect of cyclosporine on colchicine partitioning in the rat liver.

Authors:  K V Speeg; A L Maldonado
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Effect of chronic administration of cyclosporin A on hepatic uptake and biliary secretion of bromosulfophthalein in rat.

Authors:  J F Cadranel; M Dumont; V A Mesa; C Degott; D Touchard; S Erlinger
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

8.  Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.

Authors:  Anke Van Summeren; Johan Renes; Daneida Lizarraga; Freek G Bouwman; Jean-Paul Noben; Joost H M van Delft; Jos C S Kleinjans; Edwin C M Mariman
Journal:  OMICS       Date:  2013-01-11

9.  Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.

Authors:  E E Emeson; M L Shen
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

Review 10.  An Update on Endoscopic Management of Post-Liver Transplant Biliary Complications.

Authors:  Hyun Woo Lee; Najmul Hassan Shah; Sung Koo Lee
Journal:  Clin Endosc       Date:  2017-04-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.